NOCC Impact Report 2016 - Page 9

RE S E AR C H INITIATIVE S NEW RESEARCH INITIATIVE: In 2014, NOCC affirmed its commitment to research with the newest RESEARCH • IN • ACTIONSM Initiative. In collaboration with Stand Up To Cancer, and the American Association for Cancer Research, along with partners Ovarian Cancer National Alliance and Ovarian Cancer Research Fund, the NOCC committed to supporting the “Ovarian Cancer Dream Team,” the first of its kind in the history of ovarian cancer research. This inter-disciplinary team consists of the best and brightest scientists, researchers, and medical experts, worldwide. Alan D’Andrea, MD, co-director of the Gene Therapy Center at Dana-Farber Cancer Institute in Boston, and the Fuller-American Cancer Society professor of Medicine at Harvard Medical School, will lead the Dream Team. Elizabeth M. Swisher, MD, professor in the Department of Obstetrics and Gynecology at the University of Washington in Seattle, will be co-leader. The Dream Team’s area of study, a three-year endeavor beginning in July 2015, is entitled “DNA Repair Therapies for Ovarian Cancer.” This area of focus will emphasize the defects in DNA repair that have been identified as a common weakness in ovarian cancer. The approach will inform the application of immunotherapy, which is treatment that uses the body’s own immune system to help fight cancer. The team will also emphasize prevention and early detection of the disease. The NOCC’s commitment to fund the Dream Team is in support of the principles associated with bringing together innovative scientists and medical experts on the disease, with the goal of working towards improved patient outcomes that can save lives now. The NOCC is thrilled to be funding this landmark research venture, and the promise of leading-edge, ovarian cancer research. OTHER RESEARCH INITIATIVES: Some of the recent research projects supported by the NOCC have included the Ann Schreiber Ovarian Cancer Research Training Program of Excellence: A Study by Dr. Ruth Perets, M.D., Ph.D., about the fallopian tubes as the origin of ovarian cancer, and the GOG-0225, also known as the LIvES Study (Lifestyle Intervention for Ovarian Cancer Enhanced Survival), conducted by the University of Arizona Cancer Center. 7